Huaota licensed in four biosimilar products from US Oncobiologics Inc. 

including Adalimumab monoclonal antibody biosimilar (project code ‘HOT-3010’) and Avastin monoclonal antibody biosimilar (project code ‘HOT-1010’)

Huaota entered into an agreement with Shanghai Junshi Biosciences Co., Ltd and Junshi acquired the Avastin monoclonal antibody biosimilar (project code "HOT-1010") from Huaota for ￥90 million.HOT-1010